News
Real-world evidence platform developer Aetion nabs Amgen-backed $36M Series B
The passage of the 21st Century Cures Act spurred growing interest in the use of ...
News
NEA backs startup’s software to assess drug performance
Venture capitalists increasingly are backing startups that blend computer science and ...
News
Aetion raises $36M, Carolyn Magill interview
TheHealthCare Blog spoke Aetion CEO Carolyn Magill to find out what Aetion does and why ...
News
Why Aetion's push for real-world data earned it $36M
Aetion, a healthcare technology company specializing in real-world data and analytics, ...
News
Big data essential in making decisions on medical treatments
Korea aims to leverage its extensive healthcare data to advance its medical industry, but ...
News
What hospitals, insurers should take away from Tom Price's resignation
Tom Price's departure as head of Health and Human Services on Friday leaves a question ...
News
Modern Healthcare people on the move
Healthcare industry veteran Carolyn Magill joins Aetion (pronounced eh-tee-ahn) as the ...
News
Three reasons why substituting real-world data for certain randomized clinical trials is inevitable
Writing in 2017, Aetion's co-founder and president Jeremy Rassen discusses how the 21st ...
News
Data science gurus: Land your next job with tips from 7 tech companies
From healthtech to retail, companies across all major industries need the help of data ...
News
Class of diabetes drug raises risk for diabetic ketoacidosis
A study published in the New England Journal of Medicine suggests that a new class of ...
News
This NYC startup raised $11.2M to make health care data accessible
If you are concerned about the future of healthcare in America you are not alone. There’s ...
News
Aetion gets $11.2M for real-world evidence analytics platform
New York-based healthcare technology company, Aetion, which makes an analytics platform ...